1,194
Views
39
CrossRef citations to date
0
Altmetric
Original Article

Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study

, , &
Pages 69-75 | Received 16 Jun 2016, Accepted 16 Aug 2016, Published online: 14 Sep 2016

References

  • Månsson J, Marklund B, Hultborn R. The diagnosis of cancer in the “roar” of potential cancer symptoms of patients in primary health care. Research by means of the computerised journal. Scand J Prim Health Care. 2001;19:83–89.
  • Viniol A, Keunecke C, Biroga T, et al. Studies of the symptom abdominal pain – a systematic review and meta-analysis. Fam Pract. 2014;31:517–529.
  • Schreuders EH, Ruco A, Rabeneck L, et al. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64:1637–1649.
  • Tinmouth J, Lansdorp-Vogelaar I, Allison JE. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know. Gut. 2015;64:1327–1337.
  • NICE Guidance [Internet]. London: National Institute of Clinical Excellence. Suspected cancer: recognition and referral (NG12). 1 Recommendations organised by site of cancer. 1.3 Lower gastrointestinal tract cancers. June 2015 [cited 2016 Jun 2]. Available from: https://www.nice.org.uk/guidance/NG12/chapter/1-Recommendations-organised-by-site-of-cancer#lower-gastrointestinal-tract-cancers.
  • Sundhetsstyrelsen [Internet]. Copenhagen: Sundhetsstyrelsen. Pakkeforløb på kræftområdet. Pakkeforløb for kræft i tyk- og endetarm [Cancer pathways. National integrated cancer pathway for colorectal cancer]; 2012 [cited 2016 Jun 2]. In Danish. Available from: http://www.sst.dk/∼/media/F857D175672540FD94B59986ED6EE4C2.ashx.
  • Hogberg C, Karling P, Rutegard J, et al. Immunochemical faecal occult blood tests in primary care and the risk of delay in the diagnosis of colorectal cancer. Scand J Prim Health Care. 2013;31:209–214.
  • Kok L, Elias SG, Witteman BJM, et al. Diagnostic accuracy of point-of-care faecal calprotectin and immunochemical occult blood tests for diagnosis of organic bowel disease in primary care: the Cost-Effectiveness of a Decision Rule for Abdominal Complaints in Primary Care (CEDAR) study. Clin Chem. 2012;58:989–998.
  • Parente F, Marino B, Ilardo A, et al. A combination of faecal tests for the detection of colon cancer: a new strategy for an appropriate selection of referrals to colonoscopy? A prospective multicentre Italian study. Eur J Gastroenterol Hepatol. 2012;24:1145–1152.
  • Kaul A, Shah A, Magill FH, et al. Immunological faecal occult blood testing: a discriminatory test to identify colorectal cancer in symptomatic patients. Int J Surg. 2013;11:329–331.
  • McDonald PJ, Digby J, Innes C, et al. Low faecal haemoglobin concentration potentially rules out significant colorectal disease. Colorectal Dis. 2013;15:e151–e159.
  • Cubiella J, Salve M, Diaz-Ondina M, et al. Diagnostic accuracy of the faecal immunochemical test for colorectal cancer in symptomatic patients: comparison with NICE and SIGN referral criteria. Colorectal Dis. 2014;16:O273–O282.
  • Mowat C, Digby J, Strachan JA, et al. Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms. Gut. 2016;65:1463–1469.
  • Rodriguez-Alonso L, Rodriguez-Moranta F, Ruiz-Cerulla A, et al. An urgent referral strategy for symptomatic patients with suspected colorectal cancer based on a quantitative immunochemical faecal occult blood test. Dig Liver Dis. 2015;47:797–804.
  • Gillberg A, Ericsson E, Granstrom F, et al. A population-based audit of the clinical use of faecal occult blood testing in primary care for colorectal cancer. Colorectal Dis. 2012;14:e539–e546.
  • Roseth AG, Fagerhol MK, Aadland E, et al. Assessment of the neutrophil dominating protein calprotectin in faeces. A methodologic study. Scand J Gastroenterol. 1992;27:793–798.
  • Tøn H, Brandsnes Ø, Dale S, et al. Improved assay for faecal calprotectin. Clin Chim Acta. 2000;292:41–54.
  • NICE Guidance [Internet]. London: National Institute of Clinical Excellence. NICE diagnostic guidance [DG11]. Faecal calprotectin diagnostic tests for inflammatory disease of the bowel; 2013 [cited 2016 Jun 2]. Available from: https://www.nice.org.uk/guidance/dg11.
  • Tibble J, Sigthorsson G, Foster R, et al. Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma. Gut. 2001;49:402–408.
  • Manz M, Burri E, Rothen C, et al. Value of faecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study. BMC Gastroenterol. 2012;12:5. DOI: 10.1186/1471-230X-12-5.
  • Pavlidis P, Chedgy FJQ, Tibble JA. Diagnostic accuracy and clinical application of faecal calprotectin in adult patients presenting with gastrointestinal symptoms in primary care. Scand J Gastroenterol. 2013;48:1048–1054.
  • Turvill J, Aghahoseini A, Sivarajasingham N, et al. Faecal calprotectin in patients with suspected colorectal cancer: a diagnostic accuracy study. Br J Gen Pract. 2016;66:e499–e506.
  • Goddard AF, James MW, McIntyre AS, et al. Guidelines for the management of iron deficiency anaemia. Gut. 2011;60:1309–1316.
  • Bager P, Befrits R, Wikman O, et al. The prevalence of anaemia and iron deficiency in IBD outpatients in Scandinavia. Scand J Gastroenterol. 2011;46:304–309.
  • Hamilton W, Lancashire R, Sharp D, et al. The importance of anaemia in diagnosing colorectal cancer: a case–control study using electronic primary care records. Br J Cancer. 2008;98:323–327.
  • Ioannou GN, Rockey DC, Bryson CL, et al. Iron deficiency and gastrointestinal malignancy: a population-based cohort study. Am J Med. 2002;113:276–280.
  • Panagiotopoulou IG, Fitzrol D, Parker RA, et al. The yield of colorectal cancer among fast track patients with normocytic and microcytic anaemia. Ann R Coll Surg Engl. 2014;96:289–293.
  • Bossuyt PM, Reitsma JB, Bruns DE, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ. 2015;351:h5527.
  • Högberg C, Samuelsson E, Lilja M, et al. Could it be colorectal cancer? General practitioners' use of the faecal occult blood test and decision making – a qualitative study. BMC Fam Pract. 2015;16:153. DOI: 10.1186/s12875-015-0371-1
  • Oy Medix Biochemica Ab [Internet]. Espoo, Finland; [cited 2016 June 2]. Available from: https://www.medixbiochemica.com
  • Calpro AS [Internet]. Oslo; [cited 2016 Jun 2]. Available from: https://calpro.no.
  • Podolsky DK, Camilleri M, Fitz JG, et al. editors. Yamada's textbook of gastroenterology. 6th ed. London (UK): Wiley; 2015.
  • Hogberg C, Asplund R. Många faeces-Hb-test till liten nytta: Immunkemisk metod ger dålig diagnoshjälp, visar primärvårdsstudie [Small benefit of many faeces-Hb tests. Low diagnostic value of the immunochemical method according to a primary health care study]. Lakartidningen. 2010;107:1372–1375. In Swedish.
  • Meucci G, D'Incà R, Maieron R, et al. Diagnostic value of faecal calprotectin in unselected outpatients referred for colonoscopy: a multicenter prospective study. Dig Liver Dis. 2010;42:191–195.
  • Mooiweer E, Fidder HH, Siersema PD, et al. Faecal haemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation. Inflamm Bowel Dis. 2014;20:307–314.
  • Pengelly S, Fabricius M, McMenamin D, et al. Attendance at iron deficiency anaemia clinic: audit of outcomes 5 years on. Colorectal Dis. 2013;15:423–427.
  • Wilson A, Reyes E, Ofman J. Prevalence and outcomes of anaemia in inflammatory bowel disease: a systematic review of the literature. Am J Med. 2004;116:44S–49S.
  • Hundt S, Haug U, Brenner H. Comparative evaluation of immunochemical faecal occult blood tests for colorectal adenoma detection. Ann Intern Med. 2009;150:162–169.
  • Allison JE, Fraser CG, Halloran SP, et al. Comparing faecal immunochemical tests: improved standardisation is needed. Gastroenterology. 2012;142:422–424.
  • Astin M, Griffin T, Neal RD, et al. The diagnostic value of symptoms for colorectal cancer in primary care: a systematic review. Br J Gen Pract. 2011;61:e231–e243.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.